HN Simulatornew | past | comments | lists | submit | derekja's commentslogin

Your website is not mobile-friendly. The pricing page, for instance, is not properly viewable.


May not completely stop it, but lecanemab and donanemab are certainly considered to be disease-progression modifying at this point.


Guidelines | FAQ | Lists | API | Security | DMCA | Apply to YC | Contact

Search: